Mounjaro 2.5mg as a maintenance dose: why the starting strength is rarely the finishing line

You've just started Mounjaro and the pharmacist has said '2.5mg for the first month', here's what that actually means

Picture the first pen arriving on a Tuesday morning. The instructions say one injection a week for four weeks at 2.5mg, and you might wonder whether this dose is doing anything meaningful for weight. Honestly? It probably isn't, not yet. The 2.5mg starting strength exists because tirzepatide activates both GIP and GLP-1 receptors simultaneously, and jumping straight to a therapeutic dose tends to produce significant nausea, vomiting and digestive discomfort. Starting low, then stepping up, keeps most people comfortable enough to stay on treatment at all.

The full Mounjaro overview on our site explains the dual-agonist mechanism in more depth, but the short version is this: 2.5mg is the adjustment period, not the treatment phase. The NHS tirzepatide medicines page reflects the same position, the starting dose is described explicitly as a tolerability measure before titration begins.

Most prescribers move patients to 5mg after those four weeks. If your gut has settled well, that step up is straightforward. If you've had a rough first month (persistent nausea, disrupted sleep, significant GI upset) a prescriber might hold at 2.5mg for a second four-week period before increasing. That's a reasonable, individualised call. It isn't the same as deciding 2.5mg will be your permanent dose.

What the trial data says about 2.5mg as a long-term maintenance strength, and why almost nobody ends up there

SURMOUNT-1, the pivotal 72-week tirzepatide trial involving around 2,500 adults with obesity, showed average weight reductions of roughly 20–21% at the 15mg dose. Those results came from participants who titrated through the full schedule, not from people who stayed at 2.5mg. The trial wasn't designed to measure the effect of 2.5mg as a standalone maintenance dose, and NICE's assessment of tirzepatide (published as technology appraisal TA1026) references the evidence base at therapeutic doses, with a specific note that continuing treatment should be reviewed if less than 5% weight loss is achieved after six months at the highest tolerated dose.

That last clause is important. If someone reaches 2.5mg and stays there for six months and hasn't lost 5% of their body weight, the clinical guidance suggests reviewing whether to continue at all, not whether to call 2.5mg a success. The dose is simply too low to produce the appetite suppression and metabolic effect that the higher strengths deliver for most people.

There is a narrow group who genuinely cannot tolerate dose increases: persistent vomiting, severe reflux or other GI conditions that make stepping up unsafe. For those individuals, a prescriber might decide to hold at 2.5mg as the best available option given the circumstances. That is a clinical judgement, made with full knowledge of someone's medical history. It's rare, and it's never a default.

If you're wondering whether staying at 2.5mg as a maintenance approach is feasible for your situation, that question deserves a direct conversation with a prescriber, not a general article.

How Mounjaro maintenance doses actually work, and what 'maintenance' really means in this context

Maintenance, in the context of Mounjaro treatment, means the dose at which you're no longer titrating upward and are instead sustaining progress. For most people that lands somewhere between 10mg and 15mg, though 5mg or 7.5mg can be the right stopping point for some. The question of what constitutes a true maintenance dose is explored in detail separately, but the core principle is straightforward: maintenance is wherever continued clinical benefit is achieved at a dose you tolerate well.

The titration schedule (2.5mg, then 5mg, then 7.5mg, stepping up roughly every four weeks) is a ladder, and 2.5mg is the lowest rung. It's worth knowing that the 5mg dose is sometimes described as a therapeutic starting point rather than an interim step, which is why some people ask whether 5mg itself counts as maintenance. Similarly, 7.5mg as a maintenance dose is a more common outcome than 2.5mg ever will be.

One practical note on timing: if you're ordering your next pen around a bank holiday or planning ahead for a week away, the 12pm weekday cut-off for same-day dispatch is worth factoring in. Running out mid-titration and restarting at a lower dose can affect your progress, so a brief conversation with your prescribing team is sensible before any gap occurs. Our FAQs section covers common questions about supply and re-ordering.

For a broader look at tirzepatide maintenance dosing across the full schedule, including how prescribers decide when to stop increasing, that page pulls together the clinical picture in one place. And if you're still at the stage of deciding whether Mounjaro is the right treatment to start, our treatment overview sets out all the options clearly.